Global Regenerative Medicine Market Size, Status and Forecast 2020-2026
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the 'process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function'. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.
USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.
Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.
The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Regenerative Medicine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Regenerative Medicine industry.
Based on our recent survey, we have several different scenarios about the Regenerative Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 8298.8 million in 2019. The market size of Regenerative Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine market in terms of revenue.
Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Regenerative Medicine market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Regenerative Medicine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine market.
The following players are covered in this report:
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.
USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.
Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.
The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Regenerative Medicine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Regenerative Medicine industry.
Based on our recent survey, we have several different scenarios about the Regenerative Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 8298.8 million in 2019. The market size of Regenerative Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine market in terms of revenue.
Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Regenerative Medicine market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Regenerative Medicine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine market.
The following players are covered in this report:
- DePuy Synthes
- Medtronic
- ZimmerBiomet
- Stryker
- Acelity
- MiMedx Group
- Organogenesis
- UniQure
- Cellular Dynamics International
- Osiris Therapeutics
- Vcanbio
- Gamida Cell
- Golden Meditech
- Cytori
- Celgene
- Vericel Corporation
- Guanhao Biotech
- Mesoblast
- Stemcell Technologies
- Bellicum Pharmaceuticals
- Cell Therapy
- Tissue Engineering
- Biomaterial
- Other
- Dermatology
- Cardiovascular
- CNS
- Orthopedic
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Regenerative Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Biomaterial
1.4.5 Other
1.5 Market by Application
1.5.1 Global Regenerative Medicine Market Share by Application: 2020 VS 2026
1.5.2 Dermatology
1.5.3 Cardiovascular
1.5.4 CNS
1.5.5 Orthopedic
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Regenerative Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Regenerative Medicine Industry
1.6.1.1 Regenerative Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Regenerative Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Regenerative Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Regenerative Medicine Market Perspective (2015-2026)
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Regenerative Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Regenerative Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Regenerative Medicine Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Regenerative Medicine Players by Market Size
3.1.1 Global Top Regenerative Medicine Players by Revenue (2015-2020)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Regenerative Medicine Market Concentration Ratio
3.2.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2019
3.3 Regenerative Medicine Key Players Head office and Area Served
3.4 Key Players Regenerative Medicine Product Solution and Service
3.5 Date of Enter into Regenerative Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Regenerative Medicine Historic Market Size by Type (2015-2020)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2021-2026)
5 REGENERATIVE MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Regenerative Medicine Market Size by Application (2015-2020)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Regenerative Medicine Market Size (2015-2020)
6.2 Regenerative Medicine Key Players in North America (2019-2020)
6.3 North America Regenerative Medicine Market Size by Type (2015-2020)
6.4 North America Regenerative Medicine Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Regenerative Medicine Market Size (2015-2020)
7.2 Regenerative Medicine Key Players in Europe (2019-2020)
7.3 Europe Regenerative Medicine Market Size by Type (2015-2020)
7.4 Europe Regenerative Medicine Market Size by Application (2015-2020)
8 CHINA
8.1 China Regenerative Medicine Market Size (2015-2020)
8.2 Regenerative Medicine Key Players in China (2019-2020)
8.3 China Regenerative Medicine Market Size by Type (2015-2020)
8.4 China Regenerative Medicine Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Regenerative Medicine Market Size (2015-2020)
9.2 Regenerative Medicine Key Players in Japan (2019-2020)
9.3 Japan Regenerative Medicine Market Size by Type (2015-2020)
9.4 Japan Regenerative Medicine Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Regenerative Medicine Market Size (2015-2020)
10.2 Regenerative Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Regenerative Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Regenerative Medicine Market Size by Application (2015-2020)
11 INDIA
11.1 India Regenerative Medicine Market Size (2015-2020)
11.2 Regenerative Medicine Key Players in India (2019-2020)
11.3 India Regenerative Medicine Market Size by Type (2015-2020)
11.4 India Regenerative Medicine Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Regenerative Medicine Market Size (2015-2020)
12.2 Regenerative Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Regenerative Medicine Market Size by Type (2015-2020)
12.4 Central & South America Regenerative Medicine Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 DePuy Synthes
13.1.1 DePuy Synthes Company Details
13.1.2 DePuy Synthes Business Overview and Its Total Revenue
13.1.3 DePuy Synthes Regenerative Medicine Introduction
13.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2015-2020))
13.1.5 DePuy Synthes Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview and Its Total Revenue
13.2.3 Medtronic Regenerative Medicine Introduction
13.2.4 Medtronic Revenue in Regenerative Medicine Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 ZimmerBiomet
13.3.1 ZimmerBiomet Company Details
13.3.2 ZimmerBiomet Business Overview and Its Total Revenue
13.3.3 ZimmerBiomet Regenerative Medicine Introduction
13.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2015-2020)
13.3.5 ZimmerBiomet Recent Development
13.4 Stryker
13.4.1 Stryker Company Details
13.4.2 Stryker Business Overview and Its Total Revenue
13.4.3 Stryker Regenerative Medicine Introduction
13.4.4 Stryker Revenue in Regenerative Medicine Business (2015-2020)
13.4.5 Stryker Recent Development
13.5 Acelity
13.5.1 Acelity Company Details
13.5.2 Acelity Business Overview and Its Total Revenue
13.5.3 Acelity Regenerative Medicine Introduction
13.5.4 Acelity Revenue in Regenerative Medicine Business (2015-2020)
13.5.5 Acelity Recent Development
13.6 MiMedx Group
13.6.1 MiMedx Group Company Details
13.6.2 MiMedx Group Business Overview and Its Total Revenue
13.6.3 MiMedx Group Regenerative Medicine Introduction
13.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2015-2020)
13.6.5 MiMedx Group Recent Development
13.7 Organogenesis
13.7.1 Organogenesis Company Details
13.7.2 Organogenesis Business Overview and Its Total Revenue
13.7.3 Organogenesis Regenerative Medicine Introduction
13.7.4 Organogenesis Revenue in Regenerative Medicine Business (2015-2020)
13.7.5 Organogenesis Recent Development
13.8 UniQure
13.8.1 UniQure Company Details
13.8.2 UniQure Business Overview and Its Total Revenue
13.8.3 UniQure Regenerative Medicine Introduction
13.8.4 UniQure Revenue in Regenerative Medicine Business (2015-2020)
13.8.5 UniQure Recent Development
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International Company Details
13.9.2 Cellular Dynamics International Business Overview and Its Total Revenue
13.9.3 Cellular Dynamics International Regenerative Medicine Introduction
13.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2015-2020)
13.9.5 Cellular Dynamics International Recent Development
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics Company Details
13.10.2 Osiris Therapeutics Business Overview and Its Total Revenue
13.10.3 Osiris Therapeutics Regenerative Medicine Introduction
13.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2015-2020)
13.10.5 Osiris Therapeutics Recent Development
13.11 Vcanbio
10.11.1 Vcanbio Company Details
10.11.2 Vcanbio Business Overview and Its Total Revenue
10.11.3 Vcanbio Regenerative Medicine Introduction
10.11.4 Vcanbio Revenue in Regenerative Medicine Business (2015-2020)
10.11.5 Vcanbio Recent Development
13.12 Gamida Cell
10.12.1 Gamida Cell Company Details
10.12.2 Gamida Cell Business Overview and Its Total Revenue
10.12.3 Gamida Cell Regenerative Medicine Introduction
10.12.4 Gamida Cell Revenue in Regenerative Medicine Business (2015-2020)
10.12.5 Gamida Cell Recent Development
13.13 Golden Meditech
10.13.1 Golden Meditech Company Details
10.13.2 Golden Meditech Business Overview and Its Total Revenue
10.13.3 Golden Meditech Regenerative Medicine Introduction
10.13.4 Golden Meditech Revenue in Regenerative Medicine Business (2015-2020)
10.13.5 Golden Meditech Recent Development
13.14 Cytori
10.14.1 Cytori Company Details
10.14.2 Cytori Business Overview and Its Total Revenue
10.14.3 Cytori Regenerative Medicine Introduction
10.14.4 Cytori Revenue in Regenerative Medicine Business (2015-2020)
10.14.5 Cytori Recent Development
13.15 Celgene
10.15.1 Celgene Company Details
10.15.2 Celgene Business Overview and Its Total Revenue
10.15.3 Celgene Regenerative Medicine Introduction
10.15.4 Celgene Revenue in Regenerative Medicine Business (2015-2020)
10.15.5 Celgene Recent Development
13.16 Vericel Corporation
10.16.1 Vericel Corporation Company Details
10.16.2 Vericel Corporation Business Overview and Its Total Revenue
10.16.3 Vericel Corporation Regenerative Medicine Introduction
10.16.4 Vericel Corporation Revenue in Regenerative Medicine Business (2015-2020)
10.16.5 Vericel Corporation Recent Development
13.17 Guanhao Biotech
10.17.1 Guanhao Biotech Company Details
10.17.2 Guanhao Biotech Business Overview and Its Total Revenue
10.17.3 Guanhao Biotech Regenerative Medicine Introduction
10.17.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2015-2020)
10.17.5 Guanhao Biotech Recent Development
13.18 Mesoblast
10.18.1 Mesoblast Company Details
10.18.2 Mesoblast Business Overview and Its Total Revenue
10.18.3 Mesoblast Regenerative Medicine Introduction
10.18.4 Mesoblast Revenue in Regenerative Medicine Business (2015-2020)
10.18.5 Mesoblast Recent Development
13.19 Stemcell Technologies
10.19.1 Stemcell Technologies Company Details
10.19.2 Stemcell Technologies Business Overview and Its Total Revenue
10.19.3 Stemcell Technologies Regenerative Medicine Introduction
10.19.4 Stemcell Technologies Revenue in Regenerative Medicine Business (2015-2020)
10.19.5 Stemcell Technologies Recent Development
13.20 Bellicum Pharmaceuticals
10.20.1 Bellicum Pharmaceuticals Company Details
10.20.2 Bellicum Pharmaceuticals Business Overview and Its Total Revenue
10.20.3 Bellicum Pharmaceuticals Regenerative Medicine Introduction
10.20.4 Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2015-2020)
10.20.5 Bellicum Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Regenerative Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Biomaterial
1.4.5 Other
1.5 Market by Application
1.5.1 Global Regenerative Medicine Market Share by Application: 2020 VS 2026
1.5.2 Dermatology
1.5.3 Cardiovascular
1.5.4 CNS
1.5.5 Orthopedic
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Regenerative Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Regenerative Medicine Industry
1.6.1.1 Regenerative Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Regenerative Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Regenerative Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Regenerative Medicine Market Perspective (2015-2026)
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Regenerative Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Regenerative Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Regenerative Medicine Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Regenerative Medicine Players by Market Size
3.1.1 Global Top Regenerative Medicine Players by Revenue (2015-2020)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Regenerative Medicine Market Concentration Ratio
3.2.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2019
3.3 Regenerative Medicine Key Players Head office and Area Served
3.4 Key Players Regenerative Medicine Product Solution and Service
3.5 Date of Enter into Regenerative Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Regenerative Medicine Historic Market Size by Type (2015-2020)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2021-2026)
5 REGENERATIVE MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Regenerative Medicine Market Size by Application (2015-2020)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Regenerative Medicine Market Size (2015-2020)
6.2 Regenerative Medicine Key Players in North America (2019-2020)
6.3 North America Regenerative Medicine Market Size by Type (2015-2020)
6.4 North America Regenerative Medicine Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Regenerative Medicine Market Size (2015-2020)
7.2 Regenerative Medicine Key Players in Europe (2019-2020)
7.3 Europe Regenerative Medicine Market Size by Type (2015-2020)
7.4 Europe Regenerative Medicine Market Size by Application (2015-2020)
8 CHINA
8.1 China Regenerative Medicine Market Size (2015-2020)
8.2 Regenerative Medicine Key Players in China (2019-2020)
8.3 China Regenerative Medicine Market Size by Type (2015-2020)
8.4 China Regenerative Medicine Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Regenerative Medicine Market Size (2015-2020)
9.2 Regenerative Medicine Key Players in Japan (2019-2020)
9.3 Japan Regenerative Medicine Market Size by Type (2015-2020)
9.4 Japan Regenerative Medicine Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Regenerative Medicine Market Size (2015-2020)
10.2 Regenerative Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Regenerative Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Regenerative Medicine Market Size by Application (2015-2020)
11 INDIA
11.1 India Regenerative Medicine Market Size (2015-2020)
11.2 Regenerative Medicine Key Players in India (2019-2020)
11.3 India Regenerative Medicine Market Size by Type (2015-2020)
11.4 India Regenerative Medicine Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Regenerative Medicine Market Size (2015-2020)
12.2 Regenerative Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Regenerative Medicine Market Size by Type (2015-2020)
12.4 Central & South America Regenerative Medicine Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 DePuy Synthes
13.1.1 DePuy Synthes Company Details
13.1.2 DePuy Synthes Business Overview and Its Total Revenue
13.1.3 DePuy Synthes Regenerative Medicine Introduction
13.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2015-2020))
13.1.5 DePuy Synthes Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview and Its Total Revenue
13.2.3 Medtronic Regenerative Medicine Introduction
13.2.4 Medtronic Revenue in Regenerative Medicine Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 ZimmerBiomet
13.3.1 ZimmerBiomet Company Details
13.3.2 ZimmerBiomet Business Overview and Its Total Revenue
13.3.3 ZimmerBiomet Regenerative Medicine Introduction
13.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2015-2020)
13.3.5 ZimmerBiomet Recent Development
13.4 Stryker
13.4.1 Stryker Company Details
13.4.2 Stryker Business Overview and Its Total Revenue
13.4.3 Stryker Regenerative Medicine Introduction
13.4.4 Stryker Revenue in Regenerative Medicine Business (2015-2020)
13.4.5 Stryker Recent Development
13.5 Acelity
13.5.1 Acelity Company Details
13.5.2 Acelity Business Overview and Its Total Revenue
13.5.3 Acelity Regenerative Medicine Introduction
13.5.4 Acelity Revenue in Regenerative Medicine Business (2015-2020)
13.5.5 Acelity Recent Development
13.6 MiMedx Group
13.6.1 MiMedx Group Company Details
13.6.2 MiMedx Group Business Overview and Its Total Revenue
13.6.3 MiMedx Group Regenerative Medicine Introduction
13.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2015-2020)
13.6.5 MiMedx Group Recent Development
13.7 Organogenesis
13.7.1 Organogenesis Company Details
13.7.2 Organogenesis Business Overview and Its Total Revenue
13.7.3 Organogenesis Regenerative Medicine Introduction
13.7.4 Organogenesis Revenue in Regenerative Medicine Business (2015-2020)
13.7.5 Organogenesis Recent Development
13.8 UniQure
13.8.1 UniQure Company Details
13.8.2 UniQure Business Overview and Its Total Revenue
13.8.3 UniQure Regenerative Medicine Introduction
13.8.4 UniQure Revenue in Regenerative Medicine Business (2015-2020)
13.8.5 UniQure Recent Development
13.9 Cellular Dynamics International
13.9.1 Cellular Dynamics International Company Details
13.9.2 Cellular Dynamics International Business Overview and Its Total Revenue
13.9.3 Cellular Dynamics International Regenerative Medicine Introduction
13.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2015-2020)
13.9.5 Cellular Dynamics International Recent Development
13.10 Osiris Therapeutics
13.10.1 Osiris Therapeutics Company Details
13.10.2 Osiris Therapeutics Business Overview and Its Total Revenue
13.10.3 Osiris Therapeutics Regenerative Medicine Introduction
13.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2015-2020)
13.10.5 Osiris Therapeutics Recent Development
13.11 Vcanbio
10.11.1 Vcanbio Company Details
10.11.2 Vcanbio Business Overview and Its Total Revenue
10.11.3 Vcanbio Regenerative Medicine Introduction
10.11.4 Vcanbio Revenue in Regenerative Medicine Business (2015-2020)
10.11.5 Vcanbio Recent Development
13.12 Gamida Cell
10.12.1 Gamida Cell Company Details
10.12.2 Gamida Cell Business Overview and Its Total Revenue
10.12.3 Gamida Cell Regenerative Medicine Introduction
10.12.4 Gamida Cell Revenue in Regenerative Medicine Business (2015-2020)
10.12.5 Gamida Cell Recent Development
13.13 Golden Meditech
10.13.1 Golden Meditech Company Details
10.13.2 Golden Meditech Business Overview and Its Total Revenue
10.13.3 Golden Meditech Regenerative Medicine Introduction
10.13.4 Golden Meditech Revenue in Regenerative Medicine Business (2015-2020)
10.13.5 Golden Meditech Recent Development
13.14 Cytori
10.14.1 Cytori Company Details
10.14.2 Cytori Business Overview and Its Total Revenue
10.14.3 Cytori Regenerative Medicine Introduction
10.14.4 Cytori Revenue in Regenerative Medicine Business (2015-2020)
10.14.5 Cytori Recent Development
13.15 Celgene
10.15.1 Celgene Company Details
10.15.2 Celgene Business Overview and Its Total Revenue
10.15.3 Celgene Regenerative Medicine Introduction
10.15.4 Celgene Revenue in Regenerative Medicine Business (2015-2020)
10.15.5 Celgene Recent Development
13.16 Vericel Corporation
10.16.1 Vericel Corporation Company Details
10.16.2 Vericel Corporation Business Overview and Its Total Revenue
10.16.3 Vericel Corporation Regenerative Medicine Introduction
10.16.4 Vericel Corporation Revenue in Regenerative Medicine Business (2015-2020)
10.16.5 Vericel Corporation Recent Development
13.17 Guanhao Biotech
10.17.1 Guanhao Biotech Company Details
10.17.2 Guanhao Biotech Business Overview and Its Total Revenue
10.17.3 Guanhao Biotech Regenerative Medicine Introduction
10.17.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2015-2020)
10.17.5 Guanhao Biotech Recent Development
13.18 Mesoblast
10.18.1 Mesoblast Company Details
10.18.2 Mesoblast Business Overview and Its Total Revenue
10.18.3 Mesoblast Regenerative Medicine Introduction
10.18.4 Mesoblast Revenue in Regenerative Medicine Business (2015-2020)
10.18.5 Mesoblast Recent Development
13.19 Stemcell Technologies
10.19.1 Stemcell Technologies Company Details
10.19.2 Stemcell Technologies Business Overview and Its Total Revenue
10.19.3 Stemcell Technologies Regenerative Medicine Introduction
10.19.4 Stemcell Technologies Revenue in Regenerative Medicine Business (2015-2020)
10.19.5 Stemcell Technologies Recent Development
13.20 Bellicum Pharmaceuticals
10.20.1 Bellicum Pharmaceuticals Company Details
10.20.2 Bellicum Pharmaceuticals Business Overview and Its Total Revenue
10.20.3 Bellicum Pharmaceuticals Regenerative Medicine Introduction
10.20.4 Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2015-2020)
10.20.5 Bellicum Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Regenerative Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Regenerative Medicine Revenue
Table 3. Ranking of Global Top Regenerative Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. Key Players of Biomaterial
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Regenerative Medicine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Regenerative Medicine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Regenerative Medicine Players to Combat Covid-19 Impact
Table 14. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Regenerative Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Regenerative Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Regenerative Medicine Market Share by Regions (2015-2020)
Table 18. Global Regenerative Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Regenerative Medicine Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Regenerative Medicine Market Growth Strategy
Table 24. Main Points Interviewed from Key Regenerative Medicine Players
Table 25. Global Regenerative Medicine Revenue by Players (2015-2020) (Million US$)
Table 26. Global Regenerative Medicine Market Share by Players (2015-2020)
Table 27. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2019)
Table 28. Global Regenerative Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Regenerative Medicine Product Solution and Service
Table 31. Date of Enter into Regenerative Medicine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 34. Global Regenerative Medicine Market Size Share by Type (2015-2020)
Table 35. Global Regenerative Medicine Revenue Market Share by Type (2021-2026)
Table 36. Global Regenerative Medicine Market Size Share by Application (2015-2020)
Table 37. Global Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 38. Global Regenerative Medicine Market Size Share by Application (2021-2026)
Table 39. North America Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Regenerative Medicine Market Share (2019-2020)
Table 41. North America Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. North America Regenerative Medicine Market Share by Type (2015-2020)
Table 43. North America Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 44. North America Regenerative Medicine Market Share by Application (2015-2020)
Table 45. Europe Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Regenerative Medicine Market Share (2019-2020)
Table 47. Europe Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Regenerative Medicine Market Share by Type (2015-2020)
Table 49. Europe Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Regenerative Medicine Market Share by Application (2015-2020)
Table 51. China Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 52. China Key Players Regenerative Medicine Market Share (2019-2020)
Table 53. China Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. China Regenerative Medicine Market Share by Type (2015-2020)
Table 55. China Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 56. China Regenerative Medicine Market Share by Application (2015-2020)
Table 57. Japan Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Regenerative Medicine Market Share (2019-2020)
Table 59. Japan Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Regenerative Medicine Market Share by Type (2015-2020)
Table 61. Japan Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Regenerative Medicine Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Regenerative Medicine Market Share (2019-2020)
Table 65. Southeast Asia Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Regenerative Medicine Market Share by Type (2015-2020)
Table 67. Southeast Asia Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Regenerative Medicine Market Share by Application (2015-2020)
Table 69. India Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 70. India Key Players Regenerative Medicine Market Share (2019-2020)
Table 71. India Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. India Regenerative Medicine Market Share by Type (2015-2020)
Table 73. India Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 74. India Regenerative Medicine Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Regenerative Medicine Market Share (2019-2020)
Table 77. Central & South America Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Regenerative Medicine Market Share by Type (2015-2020)
Table 79. Central & South America Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Regenerative Medicine Market Share by Application (2015-2020)
Table 81. DePuy Synthes Company Details
Table 82. DePuy Synthes Business Overview
Table 83. DePuy Synthes Product
Table 84. DePuy Synthes Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 85. DePuy Synthes Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Product
Table 89. Medtronic Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 90. Medtronic Recent Development
Table 91. ZimmerBiomet Company Details
Table 92. ZimmerBiomet Business Overview
Table 93. ZimmerBiomet Product
Table 94. ZimmerBiomet Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 95. ZimmerBiomet Recent Development
Table 96. Stryker Company Details
Table 97. Stryker Business Overview
Table 98. Stryker Product
Table 99. Stryker Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 100. Stryker Recent Development
Table 101. Acelity Company Details
Table 102. Acelity Business Overview
Table 103. Acelity Product
Table 104. Acelity Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 105. Acelity Recent Development
Table 106. MiMedx Group Company Details
Table 107. MiMedx Group Business Overview
Table 108. MiMedx Group Product
Table 109. MiMedx Group Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 110. MiMedx Group Recent Development
Table 111. Organogenesis Company Details
Table 112. Organogenesis Business Overview
Table 113. Organogenesis Product
Table 114. Organogenesis Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 115. Organogenesis Recent Development
Table 116. UniQure Business Overview
Table 117. UniQure Product
Table 118. UniQure Company Details
Table 119. UniQure Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 120. UniQure Recent Development
Table 121. Cellular Dynamics International Company Details
Table 122. Cellular Dynamics International Business Overview
Table 123. Cellular Dynamics International Product
Table 124. Cellular Dynamics International Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 125. Cellular Dynamics International Recent Development
Table 126. Osiris Therapeutics Company Details
Table 127. Osiris Therapeutics Business Overview
Table 128. Osiris Therapeutics Product
Table 129. Osiris Therapeutics Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 130. Osiris Therapeutics Recent Development
Table 131. Vcanbio Company Details
Table 132. Vcanbio Business Overview
Table 133. Vcanbio Product
Table 134. Vcanbio Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 135. Vcanbio Recent Development
Table 136. Gamida Cell Company Details
Table 137. Gamida Cell Business Overview
Table 138. Gamida Cell Product
Table 139. Gamida Cell Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 140. Gamida Cell Recent Development
Table 141. Golden Meditech Company Details
Table 142. Golden Meditech Business Overview
Table 143. Golden Meditech Product
Table 144. Golden Meditech Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 145. Golden Meditech Recent Development
Table 146. Cytori Company Details
Table 147. Cytori Business Overview
Table 148. Cytori Product
Table 149. Cytori Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 150. Cytori Recent Development
Table 151. Celgene Company Details
Table 152. Celgene Business Overview
Table 153. Celgene Product
Table 154. Celgene Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 155. Celgene Recent Development
Table 156. Vericel Corporation Company Details
Table 157. Vericel Corporation Business Overview
Table 158. Vericel Corporation Product
Table 159. Vericel Corporation Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 160. Vericel Corporation Recent Development
Table 161. Guanhao Biotech Company Details
Table 162. Guanhao Biotech Business Overview
Table 163. Guanhao Biotech Product
Table 164. Guanhao Biotech Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 165. Guanhao Biotech Recent Development
Table 166. Mesoblast Company Details
Table 167. Mesoblast Business Overview
Table 168. Mesoblast Product
Table 169. Mesoblast Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 170. Mesoblast Recent Development
Table 171. Stemcell Technologies Company Details
Table 172. Stemcell Technologies Business Overview
Table 173. Stemcell Technologies Product
Table 174. Stemcell Technologies Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 175. Stemcell Technologies Recent Development
Table 176. Bellicum Pharmaceuticals Company Details
Table 177. Bellicum Pharmaceuticals Business Overview
Table 178. Bellicum Pharmaceuticals Product
Table 179. Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 180. Bellicum Pharmaceuticals Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
Table 1. Regenerative Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Regenerative Medicine Revenue
Table 3. Ranking of Global Top Regenerative Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. Key Players of Biomaterial
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Regenerative Medicine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Regenerative Medicine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Regenerative Medicine Players to Combat Covid-19 Impact
Table 14. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Regenerative Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Regenerative Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Regenerative Medicine Market Share by Regions (2015-2020)
Table 18. Global Regenerative Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Regenerative Medicine Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Regenerative Medicine Market Growth Strategy
Table 24. Main Points Interviewed from Key Regenerative Medicine Players
Table 25. Global Regenerative Medicine Revenue by Players (2015-2020) (Million US$)
Table 26. Global Regenerative Medicine Market Share by Players (2015-2020)
Table 27. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2019)
Table 28. Global Regenerative Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Regenerative Medicine Product Solution and Service
Table 31. Date of Enter into Regenerative Medicine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 34. Global Regenerative Medicine Market Size Share by Type (2015-2020)
Table 35. Global Regenerative Medicine Revenue Market Share by Type (2021-2026)
Table 36. Global Regenerative Medicine Market Size Share by Application (2015-2020)
Table 37. Global Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 38. Global Regenerative Medicine Market Size Share by Application (2021-2026)
Table 39. North America Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Regenerative Medicine Market Share (2019-2020)
Table 41. North America Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 42. North America Regenerative Medicine Market Share by Type (2015-2020)
Table 43. North America Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 44. North America Regenerative Medicine Market Share by Application (2015-2020)
Table 45. Europe Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Regenerative Medicine Market Share (2019-2020)
Table 47. Europe Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Regenerative Medicine Market Share by Type (2015-2020)
Table 49. Europe Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Regenerative Medicine Market Share by Application (2015-2020)
Table 51. China Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 52. China Key Players Regenerative Medicine Market Share (2019-2020)
Table 53. China Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 54. China Regenerative Medicine Market Share by Type (2015-2020)
Table 55. China Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 56. China Regenerative Medicine Market Share by Application (2015-2020)
Table 57. Japan Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Regenerative Medicine Market Share (2019-2020)
Table 59. Japan Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Regenerative Medicine Market Share by Type (2015-2020)
Table 61. Japan Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Regenerative Medicine Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Regenerative Medicine Market Share (2019-2020)
Table 65. Southeast Asia Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Regenerative Medicine Market Share by Type (2015-2020)
Table 67. Southeast Asia Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Regenerative Medicine Market Share by Application (2015-2020)
Table 69. India Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 70. India Key Players Regenerative Medicine Market Share (2019-2020)
Table 71. India Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 72. India Regenerative Medicine Market Share by Type (2015-2020)
Table 73. India Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 74. India Regenerative Medicine Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Regenerative Medicine Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Regenerative Medicine Market Share (2019-2020)
Table 77. Central & South America Regenerative Medicine Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Regenerative Medicine Market Share by Type (2015-2020)
Table 79. Central & South America Regenerative Medicine Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Regenerative Medicine Market Share by Application (2015-2020)
Table 81. DePuy Synthes Company Details
Table 82. DePuy Synthes Business Overview
Table 83. DePuy Synthes Product
Table 84. DePuy Synthes Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 85. DePuy Synthes Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Product
Table 89. Medtronic Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 90. Medtronic Recent Development
Table 91. ZimmerBiomet Company Details
Table 92. ZimmerBiomet Business Overview
Table 93. ZimmerBiomet Product
Table 94. ZimmerBiomet Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 95. ZimmerBiomet Recent Development
Table 96. Stryker Company Details
Table 97. Stryker Business Overview
Table 98. Stryker Product
Table 99. Stryker Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 100. Stryker Recent Development
Table 101. Acelity Company Details
Table 102. Acelity Business Overview
Table 103. Acelity Product
Table 104. Acelity Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 105. Acelity Recent Development
Table 106. MiMedx Group Company Details
Table 107. MiMedx Group Business Overview
Table 108. MiMedx Group Product
Table 109. MiMedx Group Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 110. MiMedx Group Recent Development
Table 111. Organogenesis Company Details
Table 112. Organogenesis Business Overview
Table 113. Organogenesis Product
Table 114. Organogenesis Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 115. Organogenesis Recent Development
Table 116. UniQure Business Overview
Table 117. UniQure Product
Table 118. UniQure Company Details
Table 119. UniQure Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 120. UniQure Recent Development
Table 121. Cellular Dynamics International Company Details
Table 122. Cellular Dynamics International Business Overview
Table 123. Cellular Dynamics International Product
Table 124. Cellular Dynamics International Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 125. Cellular Dynamics International Recent Development
Table 126. Osiris Therapeutics Company Details
Table 127. Osiris Therapeutics Business Overview
Table 128. Osiris Therapeutics Product
Table 129. Osiris Therapeutics Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 130. Osiris Therapeutics Recent Development
Table 131. Vcanbio Company Details
Table 132. Vcanbio Business Overview
Table 133. Vcanbio Product
Table 134. Vcanbio Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 135. Vcanbio Recent Development
Table 136. Gamida Cell Company Details
Table 137. Gamida Cell Business Overview
Table 138. Gamida Cell Product
Table 139. Gamida Cell Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 140. Gamida Cell Recent Development
Table 141. Golden Meditech Company Details
Table 142. Golden Meditech Business Overview
Table 143. Golden Meditech Product
Table 144. Golden Meditech Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 145. Golden Meditech Recent Development
Table 146. Cytori Company Details
Table 147. Cytori Business Overview
Table 148. Cytori Product
Table 149. Cytori Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 150. Cytori Recent Development
Table 151. Celgene Company Details
Table 152. Celgene Business Overview
Table 153. Celgene Product
Table 154. Celgene Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 155. Celgene Recent Development
Table 156. Vericel Corporation Company Details
Table 157. Vericel Corporation Business Overview
Table 158. Vericel Corporation Product
Table 159. Vericel Corporation Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 160. Vericel Corporation Recent Development
Table 161. Guanhao Biotech Company Details
Table 162. Guanhao Biotech Business Overview
Table 163. Guanhao Biotech Product
Table 164. Guanhao Biotech Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 165. Guanhao Biotech Recent Development
Table 166. Mesoblast Company Details
Table 167. Mesoblast Business Overview
Table 168. Mesoblast Product
Table 169. Mesoblast Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 170. Mesoblast Recent Development
Table 171. Stemcell Technologies Company Details
Table 172. Stemcell Technologies Business Overview
Table 173. Stemcell Technologies Product
Table 174. Stemcell Technologies Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 175. Stemcell Technologies Recent Development
Table 176. Bellicum Pharmaceuticals Company Details
Table 177. Bellicum Pharmaceuticals Business Overview
Table 178. Bellicum Pharmaceuticals Product
Table 179. Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2015-2020) (Million US$)
Table 180. Bellicum Pharmaceuticals Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2026
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2026
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Regenerative Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Regenerative Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Regenerative Medicine Market Share by Players in 2019
Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2019
Figure 20. North America Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. DePuy Synthes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. DePuy Synthes Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 29. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 31. ZimmerBiomet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ZimmerBiomet Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 33. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Stryker Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 35. Acelity Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Acelity Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 37. MiMedx Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 39. Organogenesis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 41. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. UniQure Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 43. Cellular Dynamics International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cellular Dynamics International Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 45. Osiris Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 47. Vcanbio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 49. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Gamida Cell Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 51. Golden Meditech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Golden Meditech Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 53. Cytori Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cytori Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 55. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Celgene Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 57. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 59. Guanhao Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 61. Mesoblast Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 63. Stemcell Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Stemcell Technologies Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 65. Bellicum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Bellicum Pharmaceuticals Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Figure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2026
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2026
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Regenerative Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Regenerative Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Regenerative Medicine Market Share by Players in 2019
Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2019
Figure 20. North America Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Regenerative Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. DePuy Synthes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. DePuy Synthes Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 29. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 31. ZimmerBiomet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ZimmerBiomet Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 33. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Stryker Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 35. Acelity Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Acelity Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 37. MiMedx Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 39. Organogenesis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 41. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. UniQure Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 43. Cellular Dynamics International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cellular Dynamics International Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 45. Osiris Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 47. Vcanbio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 49. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Gamida Cell Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 51. Golden Meditech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Golden Meditech Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 53. Cytori Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cytori Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 55. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Celgene Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 57. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 59. Guanhao Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 61. Mesoblast Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 63. Stemcell Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Stemcell Technologies Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 65. Bellicum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Bellicum Pharmaceuticals Revenue Growth Rate in Regenerative Medicine Business (2015-2020)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
